KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Cost of Revenue (2018 - 2025)

Progyny (PGNY) has disclosed Cost of Revenue for 8 consecutive years, with $18.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue changed N/A to $18.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $760.6 million, a N/A change, with the full-year FY2025 number at $72.1 million, down 92.11% from a year prior.
  • Cost of Revenue was $18.0 million for Q4 2025 at Progyny, down from $240.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $253.9 million in Q2 2025 to a low of -$116.3 million in Q4 2022.
  • A 5-year average of $74.4 million and a median of $16.5 million in 2024 define the central range for Cost of Revenue.
  • Biggest YoY gain for Cost of Revenue was 3369.56% in 2022; the steepest drop was 213.51% in 2022.
  • Progyny's Cost of Revenue stood at $102.4 million in 2021, then tumbled by 213.51% to -$116.3 million in 2022, then soared by 112.82% to $14.9 million in 2023, then increased by 10.37% to $16.5 million in 2024, then grew by 9.3% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Cost of Revenue are $18.0 million (Q4 2025), $240.5 million (Q3 2025), and $253.9 million (Q2 2025).